CompletedPhase 2NCT00301834
Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
Studying Diamond-Blackfan anemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of California, San Francisco
- Principal Investigator
- Morton J. Cowan, MDUniversity of California, San Francisco
- Intervention
- alemtuzumab(biological)
- Enrollment
- 35 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2005 – 2011
Study locations (2)
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
- University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00301834 on ClinicalTrials.govOther trials for Diamond-Blackfan anemia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07476183Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan AnemiaApriligen, Inc.
- RECRUITINGNANCT07186179Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)Northwell Health
- RECRUITINGPHASE2NCT03214354Nonmyeloablative Stem Cell Transplant in Children with Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling DonorUniversity of Calgary
- RECRUITINGNCT02720679Investigation of the Genetics of Hematologic DiseasesSt. Jude Children's Research Hospital
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT01966367CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell TransplantationDiane George
- RECRUITINGNCT00106015Diamond Blackfan Anemia Registry (DBAR)Northwell Health
- RECRUITINGNANCT00027274Cancer in Inherited Bone Marrow Failure SyndromesNational Cancer Institute (NCI)